N/A
Manufactured by Avondale Pharmaceuticals, LLC
11,184 FDA adverse event reports analyzed
Last updated: 2026-04-15
POTASSIUM IODIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Avondale Pharmaceuticals, LLC. The most commonly reported adverse reactions for POTASSIUM IODIDE include DIARRHOEA, DYSPNOEA, SEPSIS, HAEMORRHAGIC STROKE, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for POTASSIUM IODIDE.
Out of 1,441 classified reports for POTASSIUM IODIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 11,184 FDA FAERS reports that mention POTASSIUM IODIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DIARRHOEA, DYSPNOEA, SEPSIS, HAEMORRHAGIC STROKE, FATIGUE, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Avondale Pharmaceuticals, LLC in connection with POTASSIUM IODIDE. Always verify the specific product and NDC with your pharmacist.